Dr. Wei Xu received his Ph.D. in Biostatistics from University of Toronto. He is currently a scientist and principle biostatistician in Princess Margaret Hospital on clinical research of cancer diseases. He is a faculty member at the Dalla Lana School of Public Health, University of Toronto and on the Editorial Board of the Journal of Medical Statistics and Informatics. Dr. Xu's research interests are statistical genetics and clinical trial design and analysis. He is the author or co-author of over 100 publications in peer-review journals.
Professor of Cell Signal Unit, Okinawa Institute of Science and Technology Graduate University. Editorial Board: Genes to Cells, Molecular Biology of the Cell, Protein and Cell, Experimental & Molecular Medicine. Awarded 1987, Princess Takamatsu Cancer Research Fund Prize, 1990 Asahi Prize, 2003 NIH Fogarty Scholar-in-Residence. Former director of the Institute of Medical Science, University of Tokyo.
Dr. Yang’s research focuses on a group of gasotransmitters, especially H2S, in the regulation of cellular functions and human diseases. Dr. Yang has received numerous awards and recognitions, including New Investigator award from the Heart and Stroke Foundation of Canada and Maureen Andrew Award from Heart and Stroke Foundation of Ontario. In his career, Dr. Yang has published ~100 peer-reviewed research articles, some of them published in high-impact journals, including as Science, Circulation, PNAS, and EMBO report etc. Their total citations are 5,951 (April 26, 2017).
Professor of Molecular and Cellular Biology and Dean at the Graduate School of Biostudies, Kyoto University. Receipt of the 1998 Prize of Princess Takamatsu Cancer Research Fund (Tokyo).
The Willa Cather Professor of Molecular Nutrition at the University of Nebraska-Lincoln. Director of the Nebraska Gateway to Nutrigenomics. Funded by NIH and NIFA/USDA. Member of AAAS, American Society for Nutrition, American Society of Physiology, Society for Experiemental Biology and Medicine, Sigma Xi, and Gamma Sigma Delta. Research interest in nutritional epigenetics, gene regulation, cell differentiation, and genome stability.
Professor at the Second Hospital of Jilin University.
Research Keywords: Cancer research, Stem Cell, Biochemistry, Bioenergetics, Biology and life sciences, Biotechnology, Breast tumors, Cancer, Clinical research, Complementary and alternative medicine, Cytochemistry, Cytometry, Pharmacology, Neuropharmacology, Gastrointestinal tumors, Immunochemistry, Leukemias, Lung cancer.
On the Editorial Board of the Chinese Journal of Lung Cancer and the Chinese Journal of Clinical Oncology
Board certified AP/CP pathologist with GI and Liver pathology fellowship training; Focused on epidemiology and biology of breast and colorectal cancers, and economics of public healthcare systems; Editorial board membership of 10 peer-reviewed journals; Outstanding reviewer awards, Gastroinst Endosc; (Co-)directorship for more than 10 CME programs; Fellowship, ACG and CAP.
I pursued my bioinformatics Ph.D. degree in the center of bioinformatics in Peking University. During my Ph.D. study, I received comprehensive training in molecular biology, biostatistics and bioinformatics including research designs, computational tool development and database implementation. With a solid background and comprehensive knowledge in bioinformatics and biological networks, I filled a postdoctoral research fellow position at the Vanderbilt University. During this period, I received excellent training in the understanding of genetics of complex diseases including cancer and pulmonary disease, and I applied my bioinformatics skills in analysis of large scale next-generation sequencing (NGS) data.
To date, I have worked in four different research areas. The first is data collection from public literature and databases to build bioinformatics tools for public use. The second is the integrative analysis of NGS data to decipher the genetic mechanism of complex disease. Thirdly, I applied network-based strategy on the interplay of tumor suppressor genes (TSGs) and oncogenes (OCGs) using the public cancer genomic/epigenetic data. Lastly, I translated my disease genomics expertise to huge marine genomic data to explore the common cell-cell communication mechanisms of metazoan.
Professor emeritus of the University of Freiburg and the University of Heidelberg & the past Scientific Director of the German Cancer Research Center in Heidelberg. Awards include the Robert-Koch-Price; the Charles S. Mott Prize; the Paul-Ehrlich-Ludwig Darmstätter-Price; & the 2008 Nobel-Prize for Medicine. Past Editor in Chief of the International Journal of Cancer and former member of the Board of Directors of the International Union against Cancer (UICC).